TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2025-02-05
公報種別公開国際商標公報
国際登録番号1824942
国際登録日2024-05-06
区分第5類(薬剤),第10類(医用機器)
商品役務Pharmaceutical preparations, formulations, or suspensions for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, embolic particles; pharmaceutical preparations for embolization therapy.,Medical apparatus and instruments for embolization; embolic devices for treating anomalies vasculature of the body; medical device, namely, vascular embolization device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated particle embolics (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical device for vascular embolization procedures; organ ischemia or infarction interventions (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations, or occlusion of blood flow in the peripheral vasculature; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised of embolic particles therefore (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical apparatus, namely全 22 件を表示, system for vascular embolization procedures; embolic devices and kits for vascular embolization and peripheral hemostasis, namely, embolization therapy system, featuring embolic particles.
基礎出願番号98258262
基礎出願日2023-11-07
基礎出願国US
出願人Instylla, Inc.
OCRテキストEMBAKC
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する

関連商標

NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
1か月前
Biohaven Therapeutics Ltd.
1か月前
ZEALAND PHARMA A/S
16日前
Aston Group Worldwide Ltd
INESSA
16日前
Biohaven Therapeutics Ltd.
REJUTRIA
23日前
Made By Brave Limited
1か月前
Made By Brave Limited
ANCIENT+BRAVE
16日前
NUTRAVALIA
LUXEOL
3か月前
MAFRA GROUP S.r.l.
MANIAC LINE
16日前
Harbin Fuerjia Technology Co., Ltd.
Voolga
16日前
Renibus Therapeutics, Inc.
2か月前
Renibus Therapeutics, Inc.
2か月前
AETHON THERAPEUTICS, INC.
2か月前
Solventum Intellectual Properties Company
2か月前
GAMBRO LUNDIA AB
2か月前
CHOI, Yeo Reum
2か月前
ZAZEN
2か月前
Velinor AG c/o Dr. iur. Adrian von Segesser
2か月前
SEBIA
2か月前
Lycored Ltd.
Lycomato
2か月前
Zhejiang Lamking Bio-Technology Co.,Ltd
Hacker SUPER
2か月前
Azurity Pharmaceuticals, Inc.
DANZITEN
2か月前
chaenggigo Co., Ltd.
CGG
2か月前
Roche Diagnostics GmbH
LUMIRA
2か月前
SEBIA
2か月前
JW PHARMACEUTICAL CORPORATION
1か月前
TIM Holding B.V.
2か月前
Modere UK Limited
2か月前
Novartis AG
2か月前
Novartis AG
2か月前
Novartis AG
2か月前
Glaxo Group Limited
2か月前
Glaxo Group Limited
2か月前
Glaxo Group Limited
2か月前
Glaxo Group Limited
2か月前
Novartis AG
2か月前
続きを見る